Friday, September 28, 2012
Medtronic, a global medical technology company based in Minneapolis, Minn., has agreed to acquire China Kanghui Holdings for approximately $816 million in cash ($30.75 per American depository share). The total value of the transaction, net of Kanghui’s cash, is expected to be approximately $755 million.
Knome, a Cambridge, Mass.-based provider of human genome interpretation systems and services, has launched its knoSYS100, the first plug-and-play, fully integrated hardware and software system designed to help researchers in medical and academic institutions interpret human whole genomes.
Thermo Fisher Scientific, a global service provider, has officially opened its molecular biology center of excellence in Vilnius, Lithuania. The new facility will provide molecular, protein and cellular biology products to better serve growing demand from life sciences customers throughout Eastern Europe and create new opportunities globally.